[
  {
    "ts": null,
    "headline": "HAE or BSX: Which Is the Better Value Stock Right Now?",
    "summary": "HAE vs. BSX: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=eb2988f8b25cdd07999e1ad1b77dc735f65f610cdef22d74bef9cd79bee7bbd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731688808,
      "headline": "HAE or BSX: Which Is the Better Value Stock Right Now?",
      "id": 131378739,
      "image": "https://media.zenfs.com/en/zacks.com/46ebfcbff417ac1bbde85ad33fa0d4be",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HAE vs. BSX: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=eb2988f8b25cdd07999e1ad1b77dc735f65f610cdef22d74bef9cd79bee7bbd9"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=0063a2dfdbb8675536845071d19793b5cd13ab3c7f6307400602d1e23f3bd908",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731688800,
      "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
      "id": 131416659,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=0063a2dfdbb8675536845071d19793b5cd13ab3c7f6307400602d1e23f3bd908"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific : Closes Acquisition of Axonics, Inc Form 8 K",
    "summary": "Boston Scientific Closes Acquisition of Axonics, Inc. MARLBOROUGH, Mass., November 15, 2024 - Boston Scientific Corporation today announced the close of its...",
    "url": "https://finnhub.io/api/news?id=047624c88768b136df9f4687991c7ec8d8f6b0816022e344adf5a6c5bd8571ba",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731686802,
      "headline": "Boston Scientific : Closes Acquisition of Axonics, Inc Form 8 K",
      "id": 131379249,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Boston Scientific Closes Acquisition of Axonics, Inc. MARLBOROUGH, Mass., November 15, 2024 - Boston Scientific Corporation today announced the close of its...",
      "url": "https://finnhub.io/api/news?id=047624c88768b136df9f4687991c7ec8d8f6b0816022e344adf5a6c5bd8571ba"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)",
    "summary": "Boston Scientific Corporation (NYSE:BSX) UBS Global Healthcare Conference November 12, 2024 10:15 AM ETCompany ParticipantsJonathan Monson - Senior Vice...",
    "url": "https://finnhub.io/api/news?id=a7479102303cc5e4ed7c5bd2db847f588d897ee326e45db955be34e05f9992e1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731683286,
      "headline": "Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)",
      "id": 131377549,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific Corporation (NYSE:BSX) UBS Global Healthcare Conference November 12, 2024 10:15 AM ETCompany ParticipantsJonathan Monson - Senior Vice...",
      "url": "https://finnhub.io/api/news?id=a7479102303cc5e4ed7c5bd2db847f588d897ee326e45db955be34e05f9992e1"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Closes Acquisition of Axonics, Inc.",
    "summary": "Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.",
    "url": "https://finnhub.io/api/news?id=2671a82e467bb91178f84d231e876824a1613e7b1ec6427ec2734cc1bb9d7ea4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731678180,
      "headline": "Boston Scientific Closes Acquisition of Axonics, Inc.",
      "id": 131378740,
      "image": "https://media.zenfs.com/en/prnewswire.com/02e6d5e710acee0e3d3509b5490e4888",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.",
      "url": "https://finnhub.io/api/news?id=2671a82e467bb91178f84d231e876824a1613e7b1ec6427ec2734cc1bb9d7ea4"
    }
  },
  {
    "ts": null,
    "headline": "Is Labcorp Stock a Good Pick for Your Portfolio Right Now?",
    "summary": "Investors are increasingly optimistic about LH due to its partnerships and operational discipline.",
    "url": "https://finnhub.io/api/news?id=d4d6ceeea1ddd61c9b1e3b18a4c75f45e74eba143c385e1f5948ef52582ef3aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731674040,
      "headline": "Is Labcorp Stock a Good Pick for Your Portfolio Right Now?",
      "id": 131372595,
      "image": "https://media.zenfs.com/en/zacks.com/41b7bdd28f63138df08f17b665d3589a",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Investors are increasingly optimistic about LH due to its partnerships and operational discipline.",
      "url": "https://finnhub.io/api/news?id=d4d6ceeea1ddd61c9b1e3b18a4c75f45e74eba143c385e1f5948ef52582ef3aa"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific closes $3.7B Axonics deal after lengthy review",
    "summary": "Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission requested more information.",
    "url": "https://finnhub.io/api/news?id=f6b64bbca241f5208a2f7c00030464603f366fcd51868a3b92db5fd9e96d8fd3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731671160,
      "headline": "Boston Scientific closes $3.7B Axonics deal after lengthy review",
      "id": 131378745,
      "image": "https://imgproxy.divecdn.com/qijANog5UtYZq9TjsJMIDGZYT4w98MHGU9cPuV5KOM0/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0JTWF9DRU8uanBn.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission requested more information.",
      "url": "https://finnhub.io/api/news?id=f6b64bbca241f5208a2f7c00030464603f366fcd51868a3b92db5fd9e96d8fd3"
    }
  },
  {
    "ts": null,
    "headline": "Should You Retain Hologic Stock in Your Portfolio Now?",
    "summary": "HOLX's strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.",
    "url": "https://finnhub.io/api/news?id=e5c74664c024b60044383375b6c6190ac72f9c0e336d28d148f1da542240faf7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731670740,
      "headline": "Should You Retain Hologic Stock in Your Portfolio Now?",
      "id": 131369771,
      "image": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HOLX's strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.",
      "url": "https://finnhub.io/api/news?id=e5c74664c024b60044383375b6c6190ac72f9c0e336d28d148f1da542240faf7"
    }
  },
  {
    "ts": null,
    "headline": "Strategic Moves in Caxton Associates' Portfolio Highlight Tesla's Prominence",
    "summary": "Insight into the Q3 2024 13F Filing Reveals Significant Adjustments and Market Trends",
    "url": "https://finnhub.io/api/news?id=00ce102b8b255abdbbea7ab7c8c4b54b617665fcd246f020d93a59eebe0804a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731636552,
      "headline": "Strategic Moves in Caxton Associates' Portfolio Highlight Tesla's Prominence",
      "id": 131364010,
      "image": "https://s.yimg.com/ny/api/res/1.2/XPdG5rp8O3V2n2gdSj54aA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NzE-/https://media.zenfs.com/en/us.finance.gurufocus/e4b88a5eecb417662c7c267cbe024771",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Insight into the Q3 2024 13F Filing Reveals Significant Adjustments and Market Trends",
      "url": "https://finnhub.io/api/news?id=00ce102b8b255abdbbea7ab7c8c4b54b617665fcd246f020d93a59eebe0804a7"
    }
  }
]